tag medicare 
World of DTC Marketing
SEPTEMBER 9, 2021
SUMMARY: Allowing Medicare to negotiate drug prices is popular with voters because the media has been focused on the high price of some drugs, but this measure won’t lead to lower healthcare costs. The Centers for Medicare and Medicaid Services (CMS) reports that Medicare fee-for-service COVID-19 hospitalizations average $24,033.
World of DTC Marketing
JUNE 23, 2021
The story of how a drug that’s never even been proven to work is now poised to rake in billions of dollars for its manufacturer, impose needless suffering on millions of families, and destabilize Medicare and Medicaid in the process, goes well beyond the failures of what should be the toughest regulatory body of the U.S. government.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
World of DTC Marketing
DECEMBER 13, 2021
As cancer survival rates rise, so do the price tags of life-saving treatments. Monthly drugs costs may reach $100,000, causing many Americans to struggle with the physical and emotional effects of high out-of-pocket medical costs. Even worse, others are completely priced out of the hope for a cure.
Healthcare Success
MAY 3, 2021
But quite often, the audience is bombarded with retail sales pitches—tons of them—for the likes of AARP, pharma brands, Medicare Advantage, hearing aids, wellness devices, retirement communities, life insurance, cosmetics and many others. They have less concern about the straight-up price tag. Simplicity is good.
Clarify Health
JULY 13, 2021
Bringing the same analytics technology used by leading banks and retailers like JPMorgan and Amazon , together with data from the Centers for Medicare Services (CMS) and electronic health records, reveals a fascinating new picture of the quality, resource effectiveness, and practice patterns of individual physicians and hospitals.
Pharmaceutical Technology
NOVEMBER 30, 2022
The company’s weight loss drug Saxenda (liraglutide) won an approval for chronic weight management in December 2014, and Wegovy (semaglude) got the same tag in 2021. Novo Nordisk is another company leading the charge in this field. In a Phase II study, CagriSema achieved a numerically higher body weight reduction of 15.6% compared to a 5.1%
Pharmaceutical Technology
NOVEMBER 30, 2022
The company’s weight loss drug Saxenda (liraglutide) won an approval for chronic weight management in December 2014, and Wegovy (semaglude) got the same tag in 2021. Novo Nordisk is another company leading the charge in this field. In a Phase II study, CagriSema achieved a numerically higher body weight reduction of 15.6% compared to a 5.1%
Expert insights. Personalized for you.
222 
Let's personalize your content